1 |
Alcon Pharmaceuticals Ltd et al v. Watson Laboratories Inc. et al |
1:11-cv-00293 |
D.Del. |
|
|
|
|
2 |
Alcon Pharmaceuticals Ltd et al v. Watson Laboratories Inc. et al |
1:11-cv-00293 |
D.Del. |
|
|
|
|
3 |
Alcon Research, Ltd. v. Watson Laboratories, Inc. |
1:17-cv-00252 |
D.Del. |
|
|
|
|
4 |
Alcon Research, Ltd. v. Watson Laboratories, Inc. |
1:16-cv-00238 |
D.Del. |
|
|
|
|
5 |
Alcon Research, Ltd. v. Watson Laboratories, Inc. |
1:16-cv-00129 |
D.Del. |
|
|
|
|
6 |
Alcon Research, Ltd. v. Watson Laboratories, Inc., et al., |
1:15-cv-01159 |
D.Del. |
|
|
|
|
7 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
8 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
9 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
10 |
Allergan Inc. et al v. Watson Laboratories Inc.-Florida |
1:10-cv-00852 |
D.Del. |
|
|
|
|
11 |
Allergan, Inc. v. Sandoz, Inc. et al |
2:12-cv-00207 |
E.D.Tex. |
|
|
|
|
12 |
Allergan, Inc. v. Sandoz, Inc. et al |
2:12-cv-00207 |
E.D.Tex. |
|
|
|
|
13 |
Allergan, Inc. v. Sandoz, Inc. et al |
2:12-cv-00207 |
E.D.Tex. |
|
|
|
|
14 |
AMARIN PHARMA, INC. et al v. WATSON LABORATORIES, INC. et al |
3:14-cv-03259 |
D.N.J. |
|
|
|
|
15 |
AMARIN PHARMA, INC. et al v. WATSON LABORATORIES, INC. et al |
3:14-cv-03259 |
D.N.J. |
|
|
|
|
16 |
ASTRAZENECA AB v. WATSON LABORATORIES, INC. et al |
3:14-cv-03428 |
D.N.J. |
|
|
|
|
17 |
AstraZeneca LP et al v. Watson Laboratories Inc. |
1:16-cv-00338 |
D.Del. |
|
|
|
|
18 |
AstraZeneca LP et al v. Watson Laboratories Inc. |
1:16-cv-00338 |
D.Del. |
|
|
|
|
19 |
AstraZeneca LP et al v. Watson Laboratories Inc. |
1:16-cv-00338 |
D.Del. |
|
|
|
|
20 |
AstraZeneca LP et al v. Watson Laboratories Inc. |
1:16-cv-00338 |
D.Del. |
|
|
|
|
21 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
22 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
23 |
Avanir Pharmaceuticals Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00258 |
D.Del. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
24 |
Avanir Pharmaceuticals Inc. v. Watson Pharmaceuticals Inc. et al |
1:12-cv-01124 |
D.Del. |
|
|
|
|
25 |
Biovail Laboratories International SRL v. Watson Pharmaceuticals, Inc. et al |
1:10-cv-21241 |
S.D.Fla. |
|
|
|
|
26 |
CELGENE CORPORATION v. NATCO PHARMA LIMITED et al |
2:12-cv-04571 |
D.N.J. |
|
|
|
|
27 |
CELGENE CORPORATION v. NATCO PHARMA LIMITED et al |
2:14-cv-03126 |
D.N.J. |
|
|
|
|
28 |
Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:08-cv-00330 |
D.Del. |
|
|
|
|
29 |
Cephalon Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:08-cv-00330 |
D.Del. |
|
|
|
|
30 |
Daiichi Sankyo Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:11-cv-00074 |
D.Del. |
|
|
|
|
31 |
Daiichi Sankyo Inc. et al v. Watson Pharmaceuticals Inc. et al |
1:11-cv-00074 |
D.Del. |
|
|
|
|
32 |
DEPOMED, INC. v. BANNER PHARMACAPS INC. et al |
2:13-cv-04542 |
D.N.J. |
|
|
|
|
33 |
DEPOMED, INC. v. BANNER PHARMACAPS INC. et al |
1:13-cv-00653 |
M.D.N.C. |
|
|
|
|
34 |
Dey v. Watson Pharmaceuticals Inc |
5:06-cv-00395 |
C.D.Cal. |
|
|
|
|
35 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS, INC. et al |
2:14-cv-02661 |
D.N.J. |
|
|
|
|
36 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS, INC. et al |
2:14-cv-02661 |
D.N.J. |
|
|
|
|
37 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
38 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
39 |
ELI LILLY AND COMPANY et al v. PERRIGO COMPANY et al |
1:13-cv-00851 |
S.D.Ind. |
|
|
|
|
40 |
FERRING B.V. et al v. ACTAVIS, INC. et al |
2:15-cv-04222 |
D.N.J. |
|
|
|
|
41 |
FERRING B.V. et al v. ACTAVIS, INC. et al |
2:15-cv-04222 |
D.N.J. |
|
|
|
|
42 |
FERRING B.V. et al v. ACTAVIS, INC. et al |
2:15-cv-04222 |
D.N.J. |
|
|
|
|
43 |
GILEAD SCIENCES, INC. et al v. SIGMAPHARM LABORATORIES, LLC. |
1:15-cv-02350 |
D.N.J. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
44 |
GILEAD SCIENCES, INC. et al v. SIGMAPHARM LABORATORIES, LLC. |
1:15-cv-02350 |
D.N.J. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
45 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
46 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
47 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
48 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
49 |
In Re: Rivastigmine Patent Litigation |
1:05-md-01661 |
S.D.N.Y. |
|
- 8 Product company
- 13 Corporate-inventor-started company
|
|
|
50 |
MCNEIL-PPC, INC. et al v. WATSON LABORATORIES, INC. |
1:15-cv-02197 |
D.N.J. |
|
|
|
|